Macitentan for the Treatment of Digital Ulcers in Systemic Sclerosis Patients
NCT01474109
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
289
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Sclerosis
Ulcers
Interventions
DRUG:
macitentan 3mg
DRUG:
macitentan 10mg
DRUG:
placebo
Sponsor
Actelion